The efficacy of a suppository based on Phenolmicin P3 and Bosexil (Mictalase®) in control of irritative symptoms in patients undergoing thulium laser enucleation of prostate: a single-center, randomized, controlled, open label, phase III study

Peer Review reports

Original Submission
22 Oct 2021	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
Resubmission - Version 3
	Submitted	Manuscript version 3
29 Dec 2021	Reviewed	Reviewer Report - Dmitry Enikeev
9 Jan 2022	Reviewed	Reviewer Report
14 Jan 2022	Reviewed	Reviewer Report
18 Jan 2022	Author responded	Author comments - Riccardo Bertolo
Resubmission - Version 4
18 Jan 2022	Submitted	Manuscript version 4
Publishing
31 Jan 2022	Editorially accepted
12 Feb 2022	Article published	10.1186/s12894-022-00974-0

Back to article page